Human papilloma virus vaccination in Nepal: an initial experience in Nepal.
Singh
Yogendra
Y
Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal. yp_singh@hotmail.com
Shah
Aarti
A
Singh
Meeta
M
Verma
Sheela
S
Shrestha
Bhakta Man
BM
Vaidya
Prabhu
P
Nakarmi
Radha Pyari
RP
Shrestha
Surendra Bb
SB
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008297:Male; D009390:Nepal / Q000453:epidemiology; D027383:Papillomaviridae / Q000472:pathogenicity*; D030361:Papillomavirus Infections / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D053918:Papillomavirus Vaccines / Q000276:immunology / Q000627:therapeutic use*; D011379:Prognosis; D002583:Uterine Cervical Neoplasms / Q000209:etiology* / Q000517:prevention & control*; D014611:Vaccination; D055815:Young Adult
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines